Literature DB >> 32011013

The involvement of oxytocin in the effects of chronic social defeat stress on emotional behaviours in adult female mandarin voles.

Wenjuan Hou1, Zhixiong He1, Yang Yang1, Wei Yuan1, Limin Wang1, Jing Zhang1, Xueni Zhang1, Wenqi Cai1, Qianqian Guo1, Fadao Tai1.   

Abstract

Chronic social defeat stress (CSDS) can induce anxiety and depression in male rodents, but the prevalence of anxiety and depression is much higher in females, and effects of CSDS on adult females and its underlying mechanism remain unclear. Oxytocin is a stress-buffering hormone in the brain that modulates the physiological effects of stress. Strikingly, research regarding the effect of oxytocin on emotional changes caused by CSDS is still lacking in females. Thus, we focused on the involvement of the oxytocin system in changes in emotional regulation induced by CSDS in female voles. Seventy-day-old female mandarin voles (Microtus mandarinus) were exposed to aggressive adult females for 14 days, and the effects of CSDS on emotion and regulation of oxytocin system were characterized. In addition, we injected vehicle, oxytocin and oxytocin receptor antagonist into the nucleus accumbens (Nacc) of female voles to investigate the involvement of Nacc oxytocin in the effect of CSDS on emotion. Herein, we reported that CSDS increased anxiety and depression-like behaviour and the circulating level of corticosterone, but decreased the number of oxytocin projections and the protein and mRNA expression levels of oxytocin receptor in the Nacc. Injection of oxytocin into the Nacc reversed the effects of CSDS on anxiety-like and depressive-like behaviour, whereas combined injections of oxytocin and oxytocin receptor antagonist eliminated these effects. In conclusion, CSDS increases the levels of anxiety and depression possibly via a reduction in oxytocin projections and the oxytocin receptor level in the Nacc. Nacc oxytocin may be involved in the effects of CSDS on emotional behaviours.
© 2020 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; depression; oxytocin receptor; social defeat; the nucleus accumbens

Mesh:

Substances:

Year:  2020        PMID: 32011013     DOI: 10.1111/ejn.14691

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in affective disorder patients.

Authors:  Birgit Ludwig; Laura Carlberg; Klemens Kienesberger; Patrick Swoboda; Marleen M M Swoboda; Alexandra Bernegger; Romina Koller; Michelle Inaner; Monika Fuxjäger; Melanie Zotter; Nicolas Schmelzle; Birgit Senft; Lisa Meisner; Daniela Fischer-Hansal; Jasmin Huber; Silvia Schoenthaler; Nestor D Kapusta; Helmuth Haslacher; Martin Aigner; Andreas Weinhaeusel; Siegfried Kasper; Alexandra Schosser
Journal:  BMC Psychiatry       Date:  2022-06-07       Impact factor: 4.144

Review 2.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

Review 3.  The oxytocin system and early-life experience-dependent plastic changes.

Authors:  Tatsushi Onaka; Yuki Takayanagi
Journal:  J Neuroendocrinol       Date:  2021-10-29       Impact factor: 3.870

Review 4.  Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.

Authors:  Carmen Ferrer-Pérez; Marina D Reguilón; José Miñarro; Marta Rodríguez-Arias
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

5.  Synergistic consequences of early-life social isolation and chronic stress impact coping and neural mechanisms underlying male prairie vole susceptibility and resilience.

Authors:  Lindsay L Sailer; Pooja P Patel; Ashley H Park; Joanna Moon; Amit Hanadari-Levy; Alexander G Ophir
Journal:  Front Behav Neurosci       Date:  2022-07-25       Impact factor: 3.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.